<%server.execute "isdev.asp"%> Sacrococcygeal myxopapillary ependymoma with anaplastic ependymoma component in an infant Chakraborti S, Kini H, Pai K G, Upadhyaya V - J Pediatr Neurosci
home : about us : ahead of print : current issue : archives search instructions : subscriptionLogin 
Users online: 152      Small font sizeDefault font sizeIncrease font size Print this page Email this page

  Table of Contents    
Year : 2012  |  Volume : 7  |  Issue : 3  |  Page : 218-220

Sacrococcygeal myxopapillary ependymoma with anaplastic ependymoma component in an infant

1 Department of Pathology, Kasturba Medical College, Karnataka, India
2 Department of Paediatric Surgery, Kasturba Medical College, Karnataka, India
3 Department of Radiology, K. S. Hegde Medical Academy, Mangalore, Karnataka, India

Date of Web Publication25-Jan-2013

Correspondence Address:
Shrijeet Chakraborti
Department of Pathology, Kasturba Medical College - Mangalore, Lighthouse Hill Road, Mangalore - 575 001, Karnataka
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1817-1745.106485

Rights and Permissions



Sacrococcygeal location of myxopapillary ependymoma (MPE) is uncommon. Local recurrence and metastases are on record inspite of its benign characteristics. We report a rare case of sacrococcygeal MPE in an 11-month-old female child who showed typical myxopapillary ependymal histology along with anaplastic ependymal component. Ki-67 labeling index in the myxopapillary component was 4-5% and in the anaplastic component was 70%. Six weeks after gross total resection of the tumor, the child presented with local recurrence and metastasis in the right inguinal lymph nodes and was treated with chemotherapy. The present case of sacrococcygeal MPE with anaplastic ependymoma component is the second case on record in the medical literature, and the first case without any syndromic features. Metastasis in this case can be explained because of the anaplastic component, with mitotic count of 5-6/high power field and high Ki-67 labeling index.

Keywords: Anaplastic ependymoma, Ki-67, myxopapillary ependymoma, sacrococcyx

How to cite this article:
Chakraborti S, Kini H, Pai K G, Upadhyaya V. Sacrococcygeal myxopapillary ependymoma with anaplastic ependymoma component in an infant. J Pediatr Neurosci 2012;7:218-20

How to cite this URL:
Chakraborti S, Kini H, Pai K G, Upadhyaya V. Sacrococcygeal myxopapillary ependymoma with anaplastic ependymoma component in an infant. J Pediatr Neurosci [serial online] 2012 [cited 2022 Jan 27];7:218-20. Available from: https://www.pediatricneurosciences.com/text.asp?2012/7/3/218/106485

   Introduction Top

Myxopapillary ependymoma (MPE) - WHO Grade I, has been primarily described in cauda equina-filum terminale region and elsewhere in the cranio-spinal axis along the ventricular system. [1] Subcutaneous sacrococcygeal location of this benign tumor is very uncommon and unusual. [2] Metastatic deposits of sacrococcygeal MPE in the regional lymph nodes, lungs, liver and bone have been reported. [2] The present case of sacrococcygeal MPE with anaplastic ependymoma component and inguinal lymph node metastasis in an infant is the second case on record in the medical literature, and the first case without any syndromic features. [3]

   Case Report Top

An 11-month-old female child, with appropriate for age social and motor milestones, presented with a subcutaneous sacrococcygeal mass of 1 month duration. The skin over the lesion was stretched but not fixed to it. The mass was firm in consistency with restricted mobility. There was no bladder bowel disturbance. Ultrasound examination showed a large, solid mass with cystic component having mixed echogenicity, measuring 6.5 × 6 × 5.5 cm in the sacrococcygeal region. Magnetic resonance imaging (MRI) of the pelvis was limited only to the axial and coronal planes in T2-weighted sequence, which exhibited a 6 × 5.8 × 5 cm solid mass located in the midline posterior pelvis. The mass straddled across the sacrococcyx and was dumbbell shaped, with almost equal pre- and post-sacral components [Figure 1]a-c. The mass within the pelvis was insinuating around the rectum, and a small part was seen extending posterior and lateral to the urinary bladder. No pelvic lymphadenopathy was noted. Provisional clinical and radiological diagnosis was sacrococcygeal teratoma of Altman type II based on anatomical location and extension.
Figure 1: (a) Coronal fat suppressed image showing a rounded hyperintense mass lesion in the posterior lower midline; (b) Axial T2 weighted image shows the hyperintense pelvic component (arrowhead) and post-sacral component of the lesion (arrow); (c) Sagittal T2 weighted image shows that the lesion has both pre-sacral (arrowhead) and post-sacral (arrow) components straddling across the sacrococcyx, and insinuating around the rectum

Click here to view

The excision of sacrococcygeal mass was performed under general anesthesia after placing the patient in a prone (jackknife) position. The rectum was packed with gauze soaked in povidone iodine to prevent contamination of surgical field. Using the posterior sacral approach, a chevron skin incision was made. The post-sacral component of tumor was mobilized, but there was difficulty in dissection of the pre-sacral component of the tumor. The patient's position was changed to laparotomy lithotomy position. On abdominal exposure, the tumor's distal margin was mobilized from the posterior rectal wall, and lateral margins from the urinary bladder, and delivered by sacral incision. During surgery, care was taken to prevent injuries to the urinary bladder, sphincter, posterior rectal wall, pre-sacral venous plexus and sacral nerve roots. Hence, the tumor was excised en block with the combined approach and coccygectomy was performed. Post-operative period was uneventful.

Morphological examination showed an irregular mass with peripherally attached fat and skeletal muscle. Cut-surface was solid-cystic with focal papillae, myxoid areas and enclosed coccyx [Figure 2]a. Microscopy revealed a tumor composed of solid and cystic areas delineated by fibrocollagenous septae. The predominant component of tumor had characteristic perivascular rosettes and papillae with vascular cores lined by cuboidal to low columnar ependymal cells having eccentric nucleus and cytoplasmic processes abutting the vessel walls, and without discernible mitotic figures. The vascular cores showed myxoid change with focal hyalinization [Figure 2]b. This predominant myxopapillary component was continuous with highly cellular areas [Figure 2]c composed of perivascular rosettes and canals, lined by cells having oval to elongated nuclei with coarse chromatin [Figure 2]d and e. Nuclear overlapping and atypia, 5-6 mitotic figures/high power field (HPF) and punctate foci of necrosis were seen in this anaplastic ependymal component of the tumor. Ki-67 labeling index in the myxopapillary component was 4-5% [Figure 2]f and in the anaplastic component was 70% [Figure 2]d and f. The tumor was seen infiltrating the fibrocollagenous stroma and skeletal muscles.
Figure 2: (a) Cut-surface with solid-cystic areas and enclosed coccyx (*); (b) papillae with myxoid fibrovascular cores lined by benign ependymal cells (H and E, ×100); (c) myxopapillary component in continuity with anaplastic ependymoma component (H and E, ×100); (d) composed of perivascular rosettes and canals (H and E, ×100; inset: High Ki-67 labeling index); (e) lined by pleomorphic cells with nuclear atypia and mitotic figures (H and E, ×400); (f) contrasting low and high Ki-67 labeling index in myxopapillary and anaplastic ependymal component (H and E, ×100); (g) Metastasis in lymph node (H and E, ×100)

Click here to view

The child presented 6 weeks later with a small recurrent pre-sacral deposit and palpable right-sided inguinal lymph nodes measuring 0.5-1 cm in diameter. Serum estimation of α-feto protein (AFP) and β-human chorionic gonadotropin (β-HCG) was within normal limits. Microscopy of the excised lymph nodes revealed metastasis of the anaplastic ependymoma component of the sacrococcygeal tumor [Figure 2]g. The patient received six cycles of Cisplatin and Etoposide. Currently, 1 year after completion of chemotherapy, there is no evidence of recurrence or further metastasis.

   Discussion Top

Till date, 75 cases of subcutaneous sacrococcygeal MPE have been described in the medical literature. [2] The reasons for occurrence in this unusual site are either metastasis or direct extension to the sacrococcygeal soft tissues from a primary in the cauda equina-filum terminale, pre-sacral, pelvic or abdominal tumor. Rarely, primary MPE in skin or soft tissue of the sacrococcygeal area, without any demonstrable connection with the spinal cord, has been documented. [4] They probably originate from the coccygeal medullary vestige, heterotopic ependymal cell rests, extradural remnants of the filum terminale or extension of the intradural filum terminale. [2] The present case was probably a direct extension of tumor from the cauda equina-filum terminale because it had a dumbbell configuration, with almost equal pre-sacral and post-sacral (subcutaneous) components and the coccyx was part of the excised tumor specimen.

The age of presentation of sacrococcygeal MPE is 2 months to 67 years, with no sex predilection, [2] which is distinct from cauda equina MPE with 6-82 years as age of presentation and male: female ratio of 2.2:1. [1] Clinically, the differential diagnoses of a lesion in the sacrococcyx are pilonidal sinus, epidermal inclusion cyst, meningocele, lipoma, sacrococcygeal teratoma and neurogenic tumors. [2],[4] Radiologically, sacrococcygeal MPE are hypointense on T1, heterogenously hyperintense on T2-weighted MRI and have heterogenous contrast enhancement. Most of them are circumscribed but others exhibit invasion into adjacent soft tissue or sacral bone. [2]

Hashish et al. recorded complications of sacrococcygeal teratoma resections such as post-operative constipation and fecal incontinence, bladder dysfunction and recurrence in 14.7%, 5.9% and 1.8%, respectively, [5] although varied incidences have been reported in different studies. Recurrence can occur due to incomplete resection with the presence of microscopic residues, non-resection of the entire coccyx, tumor spillage or nature of tumor per se. [5] The most common post-operative complication is wound infection in 15-20% of the cases, and other uncommon complications are draining sinus, wound dehiscence and rectoperineal fistula. [6] Although the present case had recurrence, there was no feature of bowel dysfunction and neuropathic bladder.

Spinal MPEs have a tendency for slow growth and local recurrence, [7] but multifocality, [8] local spinal dissemination, [9] intracranial [10] and extraneural metastasis [7] have also been described. Secondary intracranial lesions were detected at presentation to 13 years after the resection of the primary spinal MPE. [10] Similarly, metastasis to regional lymph nodes, lungs, liver or bone has been found in 20% of subcutaneous sacrococcygeal MPE, with metastases developing 10-20 years after the initial presentation. [2] According to Helwig et al., presence of 1-2 mitotic figures/HPF in occasional cases did not correlate with the metastatic behavior of sacrococcygeal MPE. [4]

Disseminated spinal MPEs had a mean Ki-67 labeling index of 2.4%, which does not signify malignant transformation. [11] Histologically, MPE with intracranial metastasis does not show features of malignancy. [10] The mean proliferation index for disseminated anaplastic ependymomas was 21%. [11] In comparison, our study showed 5-6 mitotic figures/HPF and Ki-67 labeling index of 70% in the anaplastic ependymoma component, which explains the metastasis to the right inguinal lymph nodes.

Singular case reports of sacrococcygeal teratoma with MPE [12] and anaplastic ependymoma [13] components are on record. Extensive sampling of our specimen did not reveal any germ cell or teratomatous component, which was further substantiated by normal serum AFP and β-HCG levels. Extradural subcutaneous ependymal tumor with myxopapillary and ependymoblastic differentiation in a case of Schinzel-Geidion syndrome [3] depicted solid and cystic areas, foci of necrosis, high mitosis and Ki-67 labeling index (40%) in the anaplastic component comparable to the present case.

Gross total resection is the best therapeutic option for MPE, and subtotal resection needs to be followed by adjuvant radiotherapy to prevent recurrence. Because the present case behaved aggressively, chemotherapy was instituted in treating this child. Long-term, regular follow-up with cranio-spinal MRI is recommended to detect recurrence or secondary deposits. [7]

Sacrococcygeal tumors in the pediatric age group should be extensively sampled to look for germ cell or teratomatous or anaplastic tumor components to institute proper management and should also be regularly followed-up with cranio-spinal MRI.

   References Top

1.McLendon RE, Rosenblum MK, Schiffer D, Weistler OD. Myxopapillary ependymoma. In: Louis DN, Ohgaki H, Weistler OD, Cavenee WK, editors. WHO Classification of Tumours of the Central Nervous System. Lyon: International Agency of Research on Cancer; 2007. p. 72-3.  Back to cited text no. 1
2.Louis DN, Reifenberger G, Brat DJ, Ellison DW. Tumours: Introduction and neuroepithelial tumours. In: Love S, Louis DN, Ellison DW, editors. Greenfield's Neuropathology. 8 th ed, Vol II. London: Hodder Arnold; 2008. p. 1821-2000.  Back to cited text no. 2
3.Beschorner R, Wehrmann M, Ernemann U, Bonin M, Horber V, Oehl-Jaschkowitz B, et al. Extradural ependymal tumor with myxopapillary and ependymoblastic differentiation in a case of Schinzel-Giedion syndrome. Acta Neuropathol 2007;113:339-46.  Back to cited text no. 3
4.Helwig EB, Stern JB. Subcutaneous sacrococcygeal myxopapillary ependymoma. A clinicopathologic study of 32 cases. Am J Clin Pathol 1984;81:156-61.  Back to cited text no. 4
5.Hashish AA, Fayad H, El-attar AA, Radwan MM, Ismael K, Ashour MH, Elhalaby E. Sacrococcygeal teratoma: Management and outcomes. Ann Paed Surg 2009;5:119-25.  Back to cited text no. 5
6.Ein SH. Resection of Sacrococcygeal Teratoma. In: Fessler RG, Sekhar LN, editors. Atlas of Neurosurgical Techniques: Spine and Peripheral Nerves. New York: Thieme; 2006. p. 723-8.  Back to cited text no. 6
7.Tzerakis N, Georgakoulias N, Kontogeorgos G, Mitsos A, Jenkins A, Orphanidis G. Intraparenchymal myxopapillary ependymoma: Case report. Neurosurgery 2004;55:981.  Back to cited text no. 7
8.Andoh H, Kawaguchi Y, Seki S, Asanuma Y, Fukuoka J, Ishizawa S, et al. Multi-focal Myxopapillary Ependymoma in the Lumbar and Sacral Regions Requiring Cranio-spinal Radiation Therapy: A Case Report. Asian Spine J 2011;5:68-72.  Back to cited text no. 8
9.Fassett DR, Pingree J, Kestle JR. The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients. Report of five cases and review of the literature. J Neurosurg 2005;102:59-64.  Back to cited text no. 9
10.Chakraborti S, Govindan A, Alapatt JP, Radhakrishnan M, Santosh V. Primary myxopapillary ependymoma of the fourth ventricle with cartilaginous metaplasia: A case report and review of the literature. Brain Tumor Pathol 2012;29:25-30.  Back to cited text no. 10
11.Rezai AR, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ. Disseminated ependymomas of the central nervous system. J Neurosurg 1996;85:618-24.  Back to cited text no. 11
12.Hany MA, Bouvier R, Ranchère D, Bergeron C, Schell M, Chappuis JP et al. Case report: A preterm infant with an extradural myxopapillary ependymoma component of a teratoma and high levels of alpha-fetprotein. Pediatr Hematol Oncol 1998;15:437-41.  Back to cited text no. 12
13.Busse C, Nazeer T, Kanwar VS, Wolden S, LaQuaglia MP, Rosenblum M. Sacrococcygeal immature teratoma with malignant ependymoma component. Pediatr Blood Cancer 2009;53:680-1.  Back to cited text no. 13


  [Figure 1], [Figure 2]

This article has been cited by
1 Pediatric spinal intramedullary anaplastic myxopapillary ependymoma: a case report
S. Joy Trybula, Nitin R. Wadhwani, Laila M. Mohammad, Sandi K. Lam, Alicia C. Lenzen, Tord D. Alden
Child's Nervous System. 2021;
[Pubmed] | [DOI]
2 Clinical Features, Treatments, and Prognostic Factors of Spinal Myxopapillary Ependymoma
FanFan Fan, Jun Zhou, YiFeng Zheng, ShengWen Liu, ZhiJian Tang, Yu Wang
World Neurosurgery. 2021; 149: e1105
[Pubmed] | [DOI]
3 Myxopapillary Ependymoma with Anaplastic Features: A Case Series and Review of the Literature
Vladimir Khristov, Ganesh Shenoy, Christine Mau, Oliver Mrowczynski, Elias Rizk, Cunfeng Pu, Charles S. Specht, Dawit Aregawi
World Neurosurgery. 2021;
[Pubmed] | [DOI]
4 Pediatric Myxopapillary Ependymomas: A Clinicopathologic Evaluation
Kathryn L. Eschbacher, Amulya Nageswara Rao, Patricia T. Greipp, Troy J. Gliem, David J. Daniels, Deepti Warad, Laurence J. Eckel, Aditya Raghunathan
Journal of Pediatric Hematology/Oncology. 2021; 43(8): e1194
[Pubmed] | [DOI]
5 Extra-axial sacral soft tissue giant cell ependymoma affecting a child: Case report and review of the literature
Silvia Planas, Ofelia Cruz, Miguel Bejarano, Asteria Albert, Carlota Rovira, Josep A. Bombi
Neuropathology. 2021; 41(2): 139
[Pubmed] | [DOI]
6 Anaplastic myxopapillary ependymoma of the sacrum: A case report
Abolfazl Rahimizadeh, Zahed Malekmohammadi, Parviz Habibollahzadeh, Walter L. Williamson, Ava Rahimizadeh
Surgical Neurology International. 2021; 12: 285
[Pubmed] | [DOI]
7 Pediatric Extraspinal Sacrococcygeal Ependymoma: Report of Two Cases and Literature Review
Francesco Fabozzi, Silvia Ceccanti, Antonella Cacchione, Giovanna Stefania Colafati, Andrea Carai, Alessandro Crocoli, Angela Mastronuzzi, Denis A. Cozzi
Diagnostics. 2021; 11(9): 1680
[Pubmed] | [DOI]
8 Anaplastic myxopapillary ependymoma: A case report and review of literature
Hiroshi Kanno, Yukiko Kanetsuna, Masamichi Shinonaga
World Journal of Clinical Oncology. 2021; 12(11): 1072
[Pubmed] | [DOI]
9 Subcutaneous Sacro Coccygeal Myxopapillary Ependymoma: A Case Report and a Comprehensive Review of the Literature Reappraising Its Current Diagnostic Approach and Management
Subramaniam Ramkumar, Cliff A Wanniang, Anju Risa Wahlang, J C Alepes Lamin
Cureus. 2021;
[Pubmed] | [DOI]
10 Subcutaneous sacrococcygeal myxopapillary ependymoma misdiagnosed as pilonidal disease
Aisling Kelly, Deirdre Nally, Stephen Crowther, Dara Kavanagh
BMJ Case Reports. 2020; 13(1): e231639
[Pubmed] | [DOI]
11 Spinal Seeding Metastasis of Myxopapillary Ependymoma: Report of Three Pediatric Patients and a Brief Literature Review
Anas Abdallah
Pediatric Neurosurgery. 2020; 55(3): 127
[Pubmed] | [DOI]
12 Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the Literature
Lorenzo Gitto, Serenella Serinelli, Kristyn Galbraith, Michael Williams, Kanish Mirchia, Michael A Galgano, Satish Krishnamurthy, Gustavo de la Roza, Mariano S Viapiano, Jamie M Walker, George Jour, Jonathan Serrano, Michael DeLorenzo, Matija Snuderl, Timothy E Richardson
Journal of Neuropathology & Experimental Neurology. 2020; 79(10): 1044
[Pubmed] | [DOI]
13 Long-Term Surgical Resection Outcomes of Pediatric Myxopapillary Ependymoma: Experience of Two Centers and Brief Literature Review
Anas Abdallah, Erhan Emel, Hasan Burak Gündüz, Özden Erhan Sofuoglu, Murad Asiltürk, Betül Güler Abdallah
World Neurosurgery. 2020; 136: e245
[Pubmed] | [DOI]


Print this article  Email this article
    Similar in PUBMED
 Related articles
    Article in PDF (868 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

   Case Report
    Article Figures

 Article Access Statistics
    PDF Downloaded134    
    Comments [Add]    
    Cited by others 13    

Recommend this journal